Eicosanoids in preeclampsia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 2, 2004, Pages 223-232

  Walsh, Scott W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Aspirin; Oxidative stress; Pregnancy; Prostacyclin; Prostaglandins; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; ICOSANOID; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE;

CLINICAL TRIAL; DRUG EFFICACY; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; LEUKOCYTE; LOW DRUG DOSE; OXIDATIVE STRESS; PATIENT COMPLIANCE; PLACENTA CIRCULATION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION;

EID: 0942279570     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.04.010     Document Type: Article

References (110)

1. N.F. Gant, G.L. Daley, S. Chand, P.J. Whalley, P.C. MacDonald, A study of angiotensin II pressor response throughout primigravid pregnancy, J. Clin. Invest. 52 (1973) 2682-2689.
2. L.M. Demers, S.G. Gabbe, Placental prostaglandin levels in pre-eclampsia, Am. J. Obstet. Gynecol. 126 (1976) 137-139.
3. R.B. Everett, R.J. Worley, P.C. MacDonald, N.F. Gant, Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy, J. Clin. Endocrinol. Metab. 46 (1978) 1007-1010.
4. J.S. Robinson, C.W. Redman, L. Clover, M.D. Mitchell, The concentrations of the prostaglandins E and F, 13 14-dihydro-15-oxo-prostaglandin F and thromboxane B2 In tissues obtained from women with and without pre-eclampsia, Prostaglandins Med. 3 (1979) 223-234.
5. K. Hillier, M.D. Smith, Prostaglandin E and F concentrations in placentae of normal, hypertensive and pre-eclamptic patients, Br. J. Obstet. Gynaecol. 88 (1981) 274-277.
6. E.B. Pedersen, N.J. Christensen, P. Christensen, P. Johannesen, H.J. Kornerup, S. Kristensen, J.G. Lauritsen, P.P. Leyssac, A. Rasmussen, M. Wohlert, Preeclampsia - a state of prostaglandin deficiency? Urinary prostaglandin excretion, the renin-aldosterone system, and circulating catecholamines in preeclampsia, Hypertension 5 (1983) 105-111.
7. G. Valenzuela, M.J. Harper, R.H. Hayashi, Uterine venous, peripheral venous, and radial arterial levels of prostaglandins E and F in women with pregnancy-induced hypertension, Am. J. Obstet. Gynecol. 145 (1983) 11-14.
8. S. Moncada, J.R. Vane, Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin, Pharmacol. Rev. 30 (1979) 293-331.
9. S. Moncada, J.R. Vane, Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls, N. Engl. J. Med. 300 (1979) 1142-1147.
10. S. Moncada, J.R. Vane, The role of prostacyclin in vascular tissue, Fed. Proc. 38 (1979) 66-71.
11. 2 have potent and differentiated actions on human uterine contractility, Prostaglandins 21 (1981) 277-286.
12. C. Omini, G.C. Folco, R. Pasargiklian, M. Fano, F. Berti, Prostacyclin (PGI2) in pregnant human uterus, Prostaglandins 17 (1979) 113-120.
13. S.J. Lye, J.R.G. Challis, Inhibition by PGI2 of myometrial activity in vivo in non-pregnant ovariectomized sheep, J. Reprod. Fertil. 66 (1982) 311-315.
14. P.J. Lewis, P. Boylan, L.A. Friedman, C.N. Hensby, I. Downing, Prostacyclin in pregnancy, Br. Med. J. 280 (1980) 1581-1582.
15. R.P. Goodman, A.P. Killam, A.R. Brash, R.A. Branch, Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension, Am. J. Obstet. Gynecol. 142 (1982) 817-822.
16. S.E. Barrow, I.A. Blair, K.A. Waddell, G.L. Shepherd, P.J. Lewis, C.T. Dollery, Prostacyclin in late pregnancy: analysis of 6-oxo-prostaglandin F1a in maternal plasma, in: P.J. Lewis, S. Moncada, J. O'Grady (Eds.), Prostacyclin in Pregnancy, Raven Press, New York, 1983, pp. 79-85.
17. L. Myatt, M.G. Elder, Inhibition of platelet aggregation by a placental substance with prostacyclin-like activity, Nature 268 (1977) 159-160.
18. M.D. Mitchell, J.G. Bibby, B.R. Hicks, A.C. Turnbull, Possible role for prostacyclin in human parturition, Prostaglandins 16 (1978) 931-937.
19. M. Jogee, L. Myatt, P. Moore, M.G. Elder, Prostacyclin production by human placental cells in short-term culture, Placenta 4 (1983) 219-230.
20. I. Rakoczi, K. Tihanyi, G. Falkay, I. Rozsa, J. Demeter, I. Gati, Prostacyclin production in trophoblast, in: P.J. Lewis, S. Moncada, J. O'Grady (Eds.), Prostacyclin in Pregnancy, Raven Press, New York, 1983, pp. 15-23.
21. K.H. Nicolaides, D.J. Craven, D.S. Kirby, G.M. Filshie, E.M. Symonds, Production of prostacyclin by tissues from human fetoplacental unit, in: P.J. Lewis, S. Moncada, J. O'Grady (Eds.), Prostacyclin in Pregnancy, Raven Press, New York, 1983, pp. 25-30.
22. U.-M. Makila, L. Viinikka, O. Ylikorkala, Increased thromboxane A2 production but normal prostacyclin by the placenta in hypertensive pregnancies, Prostaglandins 27 (1984) 87-95.
23. J.Y. Jeremy, M.A. Barradas, I.L. Craft, D.P. Mikhailidis, P. Dandona, Does human placenta produce prostacyclin? Placenta 6 (1985) 45-52.
24. S.W. Walsh, M.J. Behr, N.H. Allen, Placental prostacyclin production in normal and toxemic pregnancies, Am. J. Obstet. Gynecol. 151 (1985) 110-115.
25. S.W. Walsh, Preeclampsia: an imbalance in placental prostacyclin and thromboxane production, Am. J. Obstet. Gynecol. 152 (1985) 335-340.
26. N.A. Terragno, A. Terragno, J.C. McGiff, Role of prostaglandins in blood vessels, Semin. Perinatol. 4 (1980) 85-90.
27. M. Kawano, N. Mon, Prostacyclin producing activity of human umbilical, placental and uterine vessels, Prostaglandins 26 (1983) 645-662.
28. K. Bjoro, T. Hovig, K.T. Stokke, S. Stray-Pedersen, Formation of prostanoids in human umbilical vessels perfused in vitro, Prostaglandins 31 (1986) 683-698.
29. M.P. Seed, K.I. Williams, D.S. Bamford, Influence of gestation on prostacyclin synthesis by the human pregnant myometrium, in: P.J. Lewis, S. Moncada, J. O'Grady (Eds.), Prostacyclin in Pregnancy, Raven Press, New York, 1983, pp. 31-36.
30. G. Remuzzi, D. Marchesi, C. Zoja, D. Muratore, G. Mecca, R. Misiani, E. Rossi, M. Barbato, P. Capetta, M.B. Donati, G. DeGaetano, Reduced umbilical and placental vascular prostacyclin in severe preeclampsia, Prostaglandins 20 (1980) 105-110.
31. F. Bussolino, C. Benedetto, M. Massobrio, G. Camussi, Maternal vascular prostacyclin activity in pre-eclampsia, Lancet 2 (8196) (1980) 702.
32. I. Downing, G.L. Shepherd, P.J. Lewis, Reduced prostacyclin production in pre-eclampsia, Lancet 2 (8208-9) (1980) 1374.
33. L.O. Carreras, G. Defreyn, E. Van Houtte, J. Vermylen, A. Van Assche, Prostacyclin and pre-eclampsia, Lancet 1 (8217) (1981) 442.
34. U.-M. Makila, L. Viinikka, O. Ylikorkala, Evidence that prostacyclin deficiency is a specific feature in preeclampsia, Am. J. Obstet. Gynecol. 148 (1984) 772-774.
35. P.J. Lewis, G.I. Shepherd, J. Ritter, S.M.T. Chan, P.J. Bolton, M. Jogee, L. Myatt, M.G. Elder, Prostacyclin and pre-eclampsia, Lancet 1 (8219) (1981) 559.
36. M. Yamaguchi, N. Mori, 6-keto prostaglandin F1a, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period, Am. J. Obstet. Gynecol. 151 (1985) 121-127.
37. O. Ylikorkala, U.-M. Makila, L. Viinikka, Amniotic fluid prostacyclin and thromboxane in normal, preeclamptic, and some other complicated pregnancies, Am. J. Obstet. Gynecol. 141 (1981) 487-490.
38. M.J.N.C. Keirse, J.J.H.M. Erwich, G. Klok, Does or can human placenta produce prostacyclin? Placenta 7 (1986) 37-42.
39. D.M. Nelson, S.W. Walsh, Thromboxane and prostacyclin production by different compartments of the human placental villus, J. Clin. Endocrinol. Metab. 68 (1989) 676-683.
40. S.W. Walsh, Y. Wang, Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia, J. Clin. Endocrinol. Metab. 80 (1995) 1888-1893.
41. C.S. Shellhaas, T. Coffman, P.J. Dargie, A.P. Killam, H.H. Kay, Intravillous eicosanoid compartmentalization and regulation of placental blood flow, J. Soc. Gynecol. Invest. 4 (1997) 58-63.
42. J.L. Mills, R. DerSimonian, E. Raymond, J.D. Morrow, L.J. Roberts, J.D. Clemens II, J.C. Hauth, P. Catalano, B. Sibai, L.B. Curet, R.J. Levine, Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study, J. Am. Med. Assoc. 282 (1999) 356-362.
43. W. Klockenbusch, T. Somville, D. Hafner, H. Strobach, K. Schror, Excretion of prostacyclin and thromboxane metabolites before, during, and after pregnancy-induced hypertension, Eur. J. Obstet. Gynecol. Reprod. Biol. 57 (1994) 47-50.
44. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel, M.K. McLaughlin, Preeclampsia: an endothelial cell disorder, Am. J. Obstet. Gynecol. 161 (1989) 1200-1204.
45. R.N. Taylor, C.J. de Groot, Y.K. Cho, K.H. Lim, Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia, Semin. Reprod. Endocrinol. 16 (1998) 17-31.
46. M.D. Mitchell, J.G. Bibby, B.R. Hicks, C.W.G. Redman, A.B.M. Anderson, A.C. Turnbull, Thromboxane B2 and human parturition: concentrations in the plasma and production in vitro, J. Endocrinol. 78 (1978) 435-441.
47. O. Ylikorkala, L. Viinikka, Thromboxane A2 in pregnancy and puerperium, Br. Med. J. 281 (1980) 1601-1602.
48. R.D. Johnson, Y. Sadovsky, C. Graham, E.Y. Anteby, K.L. Polakoski, X. Huang, D.M. Nelson, The expression and activity of prostaglandin H synthase-2 is enhanced in trophoblast from women with preeclampsia, J. Clin. Endocrinol. Metab. 82 (1997) 3059-3062.
49. Z.Q. Ding, J. Rowe, M.J. Sinosich, D.M. Saunders, E.D.M. Gallery, In-vitro secretion of prostanoids by placental villous cytotrophoblasts in pre-eclampsia, Placenta 17 (1996) 407-411.
50. M. Cervar, F. Kainer, C.J. Jones, G. Desoye, Altered release of endothelin-1,2 and thromboxane B2 from trophoblastic cells in pre-eclampsia, Eur. J. Clin. Invest. 26 (1996) 30-37.
51. S.H. Woodworth, X. Li, Z.M. Lei, C.V. Rao, M.A. Yussman, J.A. Spinnato, C. Yokoyama II, T. Tanabe, V. Ullrich, Eicosanoid biosynthetic enzymes in placental and decidual tissues from preeclamptic pregnancies: increased expression of thromboxane-A2 synthase gene, J. Clin. Endocrinol. Metab. 78 (1994) 1225-1231.
52. S.W. Walsh, Y. Wang, R. Jesse, Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia, Hypertens. Pregnancy 15 (1996) 101-111.
53. S. Takagi, K. Den, Prostacyclin and thromboxane A2 in preeclamptic umbilical circulation, in: O. Hayaishi, S. Yamamoto (Eds.), Kyoto Conference on Prostaglandins, Advances in Prostaglandin, Thromboxane, and Leukotriene Research, Vol. 15, Raven Press, New York, 1985, pp. 619-621.
54. L. Makarainen, O. Ylikorkala, Amniotic fluid 6-keto-prostaglandin F1 alpha and thromboxane B2 during labor, Am. J. Obstet. Gynecol. 150 (1984) 765-768.
55. Y.P. Wang, S.W. Walsh, J.D. Guo, J.Y. Zhang, Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy, Am. J. Obstet. Gynecol. 165 (1991) 1690-1694.
56. W. Klockenbusch, T.W. Goecke, J.S. Krussel, B.A. Tutschek, G. Crombach, K. Schror, Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia, Gynecol. Obstet. Invest. 50 (2000) 103-107.
57. K. Pomerantz, A. Sintetos, P. Ramwell, The effect of prostacyclin on the human umbilical artery, Prostaglandins 15 (1978) 1035-1044.
58. T. Tuvemo, Role of prostaglandins, prostacyclin, and thromboxanes in the control of the umbilical-placental circulation, Semin. Perinatol. 4 (1980) 91-95.
59. T. Tuvemo, Action of prostaglandins and blockers of prostaglandin synthesis on the isolated human umbilical artery, Adv. Prostaglandin Thromboxane Res. 4 (1978) 271-274.
60. S. Cassin, Role of prostaglandins and thromboxanes in the control of the pulmonary circulation in the fetus and newborn, Semin. Perinatol. 4 (1980) 101-107.
61. F. Coceani, P.M. Olley, Role of prostaglandins, prostacyclin, and thromboxanes in the control of prenatal patency and postnatal closure of the ductus arteriosus, Semin. Perinatol. 4 (1980) 109-113.
62. V.M. Parisi, S.W. Walsh, Fetoplacental vascular responses to prostacyclin after thromboxane-induced vasoconstriction, Am. J. Obstet. Gynecol. 160 (1989) 502-507.
63. B.J. Trudinger, A.J. Connelly, W.B. Giles, J.R. Hales, G.R. Wilcox, The effects of prostacyclin and thromboxane analogue (U46619) on the fetal circulation and umbilical flow velocity waveforms, J. Dev. Physiol. 11 (1989) 179-184.
64. C.A. Hubel, Oxidative stress in the pathogenesis of preeclampsia, Proc. Soc. Exp. Biol. Med. 222 (1999) 222-235.
65. S.W. Walsh, Lipid peroxidation in pregnancy, Hypertens. Pregnancy 13 (1994) 1-32.
66. S.W. Walsh, Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia, Semin. Reprod. Endocrinol. 16 (1998) 93-104.
67. Y.P. Wang, S.W. Walsh, J.D. Guo, J.Y. Zhang, The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood, Am. J. Obstet. Gynecol. 165 (1991) 1695-1700.
68. C.A. Hubel, M.K. McLaughlin, R.W. Evans, B.A. Hauth, C.J. Sims, J.M. Roberts, Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 h post partum, Am. J. Obstet. Gynecol. 174 (1996) 975-982.
69. D.W. Branch, M.D. Mitchell, E. Miller, W. Palinski, J.L. Witztum, Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein, Lancet 343 (1994) 645-646.
70. A. Barden, L.J. Beilin, J. Ritchie, K.D. Croft, B.N. Walters, C.A. Michael, Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy, Clin. Sci. 91 (1996) 711-718.
71. F. Diedrich, A. Renner, W. Rath, W. Kuhn, E. Wieland, Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation, Am. J. Obstet. Gynecol. 185 (2001) 166-172.
72. S.W. Walsh, The role of oxidative stress and antioxidants in preeclampsia, Contemp. Obstet. Gynecol. 42 (1997) 113-124.
73. A.M. Roggensack, Y. Zhang, S.T. Davidge, Evidence for peroxynitrite formation in the vasculature of women with preeclampsia, Hypertension 33 (1999) 83-89.
74. M.S. Mikhail, A. Anyaegbunam, D. Garfinkel, P.R. Palan, J. Basu, S.L. Romney, Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, α-tocopherol, and beta-carotene in women with preeclampsia, Am. J. Obstet. Gynecol. 171 (1994) 150-157.
75. C.A. Hubel, V.E. Kagan, E.R. Kisin, M.K. McLaughlin, J.M. Roberts, Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: implications for oxidative stress, Free Radical Biol. Med. 23 (1997) 597-609.
76. E. Gratacos, E. Casals, R. Deulofeu, V. Cararach, P.L. Alonso, A. Fortuny, Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy, Am. J. Obstet. Gynecol. 178 (1998) 1072-1076.
77. E. Schiff, S.A. Friedman, M. Stampfer, L. Kao, P.H. Barrett, B.M. Sibai, Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia, Am. J. Obstet. Gynecol. 175 (1996) 1024-1028.
78. B. Lorentzen, M.J. Endresen, T. Clausen, T. Henriksen, Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia, Hypertens. Pregnancy 13 (1994) 103-109.
79. B. Lorentzen, C.A. Drevon, M.J. Endresen, T. Henriksen, Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy, Br. J. Obstet. Gynaecol. 102 (1995) 530-537.
80. E. Gratacos, E. Casals, C. Sanllehy, V. Cararach, P.L. Alonso, A. Fortuny, Variation in lipid levels during pregnancy in women with different types of hypertension, Acta Obstet. Gynecol. Scand. 75 (1996) 896-901.
81. B. Frei, L. England, B.N. Ames, Ascorbate is an outstanding antioxidant in human blood plasma, Proc. Natl. Acad. Sci. 86 (1989) 6377-6381.
82. Y. Wang, S.W. Walsh, H.H. Kay, Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia, Am. J. Obstet. Gynecol. 167 (1992) 946-949.
83. A.-K. Poranen, U. Ekblad, P. Uotila, M. Ahotupa, Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies, Placenta 17 (1996) 401-405.
84. S.W. Walsh, J.E. Vaughan, Y. Wang, L.J. Roberts II, Placental isoprostane is significantly increased in preeclampsia, FASEB J. 14 (2000) 1289-1296.
85. L. Myatt, R.B. Rosenfield, A.L. Eis, D.E. Brockman, I. Greer, F. Lyall, Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action, Hypertension 28 (1996) 488-493.
86. P.L. Zusterzeel, H. Rutten, H.M. Roelofs, W.H. Peters, E.A. Steegers, Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress, Placenta 22 (2001) 213-219.
87. Y. Wang, S.W. Walsh, Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia, Placenta 22 (2001) 206-212.
88. S.W. Walsh, Y. Wang, Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides, Am. J. Obstet. Gynecol. 169 (1993) 1456-1461.
89. Y. Wang, S.W. Walsh, Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas, J. Soc. Gynecol. Invest. 3 (1996) 179-184.
90. S.W. Walsh, Y. Wang, R. Jesse, Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane, Am. J. Obstet. Gynecol. 169 (1993) 1007-1012.
91. M.E. Hemler, H.W. Cook, W.E. Lands, Prostaglandin biosynthesis can be triggered by lipid peroxides, Arch Biochem. Biophys. 193 (1979) 340-345.
92. M.A. Warso, W.E. Lands, Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology, Br. Med. Bull. 39 (1983) 277-280.
93. J.A. Wang, E.Z. Zhen, Z.Z. Guo, Y.C. Lu, Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of antioxidants, Free Radical Biol. Med. 7 (1989) 243-249.
94. P.N. Baker, S.T. Davidge, J. Barankiewicz, J.M. Roberts, Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin, Hypertension 27 (1996) 56-61.
95. B. Lorentzen, M.J. Endresen, T. Hovig, E. Haug, T. Henriksen, Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells, Thromb. Res. 63 (1991) 363-372.
96. P. Takacs, S.W. Kauma, M.M. Sholley, S.W. Walsh, M.J. Dinsmoor, K. Green, Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells, FASEB J. 15 (2001) 279-281.
97. P.J. Barnes, M. Karin, Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases, N. Engl. J. Med. 336 (1997) 1066-1071.
98. E. Schiff, E. Peleg, M. Goldenberg, T. Rosenthal, E. Ruppin, M. Tamarkin, G. Barkai, G. Ben-Baruch, I. Yahal, J. Blankstein, B. Goldman, S. Mashiach, The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N. Engl. J. Med. 321 (1989) 351-356.
99. A. Benigni, G. Gregorini, T. Frusca, C. Chiabrando, S. Ballerini, A. Valcamonico, S. Orisio, A. Piccinelli, V. Pinciroli, R. Fanelli, A. Gastaldi, G. Remuzzi, Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension, N. Engl. J. Med. 321 (1989) 357-362.
100. J.C. Hauth, F.G. Cunningham, Low-dose aspirin during pregnancy, in: F.G. Cunningham, P.C. MacDonald, N.F. Gant, K.J. Leveno, L.C. Gilstrap (Eds.), Williams Obstetrics Supplement, Vol. 14, Appleton & Lange, Norwalk, CT, 1995, pp. S1-S14.
101. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group, Lancet 343 (1994) 619-629.
102. B.M. Sibai, S.N. Caritis, E. Thom, M. Klebanoff, D. McNellis, L. Rocco, R.H. Paul, R. Romero, F. Witter, M. Rosen, et al., Prevention of preeclampsia with low-dose aspirin in healthy nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, N. Engl. J. Med. 329 (1993) 1213-1218.
103. J. Hauth, J. Owen, E. Thom, R. Goldenberg, B. Sibai, D. McNellis, Prevention of preeclampsia with low-dose aspirin in nulliparas: a compliance analysis [Abstract #56], in: Scientific Program and Abstracts 43rd Meeting, Philadelphia, PA, March 20-23, 1996; J. Soc. Gynecol. Invest. 3(2) (1996) 86A.
104. G. Chen, R. Wilson, G. Cumming, J.J. Walker, J.H. McKillop, Production of prostacyclin and thromboxane A2 in mononuclear cells from preeclamptic women, Am. J. Obstet. Gynecol. 169 (1993) 1106-1111.
105. S.W. Walsh, Y. Wang, Maternal perfusion with low-dose aspirin preferentially inhibits placental thromboxane while sparing prostacyclin, Hypertens. Pregnancy 17 (1998) 203-215.
106. O. Ylikorkala, U.M. Makila, P. Kaapa, L. Viinikka, Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans, Am. J. Obstet. Gynecol. 155 (1986) 345-349.
107. S.W. Walsh, Y. Wang, H.H. Kay, M.C. McCoy, Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women, Am. J. Obstet. Gynecol. 167 (1992) 926-930.
108. Y. Wang, S.W. Walsh, Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas, Free Radical Biol. Med. 18 (1995) 585-591.
109. L.C. Chappell, P.T. Seed, A.L. Briley, F.J. Kelly, R. Lee, B.J. Hunt, K. Parmar, S.J. Bewley, A.H. Shennan, P.J. Steer, L. Poston, Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial, Lancet 354 (1999) 810-816.
110. H. Seki, K. Kuromaki, S. Takeda, K. Kinoshita, K. Satoh, Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia, Hypertens. Pregnancy 18 (1999) 157-164.